← Back to catalogue

Polyflux

FDA UDI

Class II (US FDA UDI)

by Gambro Dialysatoren GmbH

Identity

Trade Name
Polyflux FDA UDI
Generic Name
Hollow-fibre haemodialysis dialyser, single-use FDA UDI
Device Name
the Polyflux 6H is intended for chronic and acute applications in haemodialysis haemofiltration and hemofiltration on small patient including pediatric indication, considering blood flow, body weight and extracoporeal blood volume FDA UDI
Model / Reference
6H FDA UDI
Description
the Polyflux 6H is intended for chronic and acute applications in haemodialysis haemofiltration and hemofiltration on small patient including pediatric indication, considering blood flow, body weight and extracoporeal blood volume FDA UDI

Identifiers

Catalog Number
103403 FDA UDI
Primary DI / UDI-DI
07332414036386 FDA UDI
510(k) Number
K051520 FDA UDI
FDA Product Code
KDI FDA UDI
GMDN Term
Hollow-fibre haemodialysis dialyser, single-use FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
876.5860 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

Yes

FDA UDI

Category: Hollow-fibre haemodialysis dialyser, single-use

Polyflux by Gambro Dialysatoren GmbH — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Hollow-fibre haemodialysis dialyser, single-use.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 2ad7f543-3d3e-48f9-bb2f-21eb86cc7494 37 fields · synced May 30, 2026